絞り込み

17352

広告

「"Growdon JH "[Author]」の検索結果

281件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

β-Glucocerebrosidase Activity in -linked Parkinson's Disease: The Type of Mutation Matters.

Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study.

Topography of cortical thinning in the Lewy body diseases.

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.

Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease.

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.

Is Alzheimer's Disease Risk Modifiable?

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.

Pathologic correlations of [F-18]-AV-1451 imaging in non-Alzheimer tauopathies.

Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.

Arguing against the proposed definition changes of PD.

The Human Alzheimer Disease Project: Answering the Call.

PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.

Validating novel tau PET tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.

Massachusetts Alzheimer's Disease Research Center: Progress and challenges.

Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease.

Putamen-midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases.

Rarity of the Alzheimer Disease-Protective APP A673T Variant in the United States.

Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
Sort by
※並べ替えは表示に時間がかかります